Pseudocholinesterase deficiency, also known as butyrylcholinesterase deficiency or plasma cholinesterase deficiency, is a rare genetic disorder that affects the activity of the enzyme pseudocholinesterase. This enzyme is responsible for breaking down certain medications, including certain muscle relaxants and local anesthetics, in the body. Individuals with pseudocholinesterase deficiency may experience prolonged effects or adverse reactions to these medications.
In the International Classification of Diseases, 10th Revision (ICD-10), the code for pseudocholinesterase deficiency is E75.2. This code falls under the section for "disorders of plasma protein metabolism, not elsewhere classified." The ICD-10 code provides a standardized way for healthcare providers to document and communicate the diagnosis of pseudocholinesterase deficiency.
In the previous version of the classification, the ICD-9 code for pseudocholinesterase deficiency was 289.8. This code was located in the section for "other diseases of blood and blood-forming organs." However, it is important to note that as of October 1, 2015, the United States transitioned from ICD-9 to ICD-10 coding system for diagnoses.
It is crucial to consult with a healthcare professional for an accurate diagnosis and appropriate management of pseudocholinesterase deficiency or any medical condition.